Trial intelligence / Profile preview

Pregabalin for Abdominal Pain From Adhesions

NCT00310765Phase 4Terminated

Sponsor
Henry Ford Health
Start
Mar 2006
Primary completion
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in abdominal pain comparing Pregabalin Group with Placebo Group (2 arms). Primary endpoint: Absolute Adhesional Abdominal Pain Score at 12 weeks. Started Mar 2006; status: terminated.

02

Drugs

pregabalin
03

Conditions

abdominal pain

Beyond the preview

Go deeper on NCT00310765.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00310765.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call